Vapotherm CEO James Liken Sells $15,956 in Stock, Removes $119,481 worth of Additional By Investing.com

In a recent transaction, James W. Liken, director at Vapotherm Inc (NYSE:OTC:), a surgical and medical device company, sold shares of the company’s common stock. On January 22, 2024, Liken sold 17,500 shares at a weighted average price of $0.9118 per share, amounting to approximately $15,956.

In addition, on September 20, 2024, Liken sold 50,308 shares at a price of $2.18 per share, as well as another 4,500 shares at the same price. These disposals, related to a merger agreement, resulted in a total of $119,481.

The transactions were disclosed in a regulatory filing with the Securities and Exchange Commission. Following the sales and dispositions, Liken appears to no longer own any shares of Vapotherm common stock. The reported prices for the shares sold and disposed of ranged from $0.88 to $0.92 and were at a fixed price of $2.18 per share, respectively.

Investors and interested parties may obtain additional details regarding the number of shares sold at each price separately upon request, as indicated in the footnotes accompanying the SEC filing. The footnotes also explain that the divestitures were part of a merger agreement that involved a cash payment for each share.

Vapotherm stock trades by insiders are closely watched by investors as they provide insight into company performance and insider perspectives on stock value.

InvestingPro Insights

As investors examine recent insider trades at Vapotherm Inc (NYSE:VAPO), it is important to consider the company’s financial health and market performance. Vapotherm, known for its medical and surgical instruments, has a market cap of $13.59 million, indicating a small-cap stock that could be subject to higher volatility and unique market risks.

InvestingPro data shows that Vapotherm has seen a significant price increase of 64.08% over the past six months, demonstrating a notable increase in stock value. This price movement is consistent with InvestingPro Advice that the stock has experienced a large increase in price over a similar time frame. This tip is particularly relevant because it coincides with the period preceding the insider trading by James W. Liken.

Another InvestingPro tip to consider is that Vapotherm is operating with a significant debt burden and has quickly eaten through cash. These factors are crucial for investors to weigh recent insider sales, as they could reflect on the company’s financial strategy and liquidity concerns. In addition, Vapotherm’s short-term liabilities exceed its liquid assets, which could signal potential liquidity constraints in the near future.

For those interested in additional information, InvestingPro offers additional advice on Vapotherm that can provide a deeper understanding of the company’s financial position and stock performance. There are currently nine additional tips listed on InvestingPro for Vapotherm, which can be accessed by visiting the company’s dedicated values ​​and analysis page.

While Liken’s recent selloff has drawn attention, this InvestingPro information can help investors form a more comprehensive view of Vapotherm’s current financial health and future prospects.

This article was generated with support from AI and reviewed by an editor. For more information, see T&C.